BCRXBioCryst Pharmaceuticals Inc

CSNasdaq (XNAS)·USD

Identity

Security key: 12344
Ticker: BCRX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 1994-03-03
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: BCRX

Detail

Enriched 2026-08-14 20:47

Market cap: $2,706,116,761.95
Shares outstanding (class): 255,535,105
Shares outstanding (weighted): 255,535,105
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 435
Location: DURHAM, NC
Homepage: https://www.biocryst.com
Description: BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Market cap and share counts drift.

Funds holding this security

122 funds · 129 positions · $448.33M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$76.31M	0.00%	8,015,652 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$63.36M	0.85%	6,655,054 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$52.84M	0.07%	5,550,200 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$27.55M	0.02%	2,894,124 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$25.56M	0.03%	2,684,396 NS	FIGI
VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS	—	$21.47M	0.21%	2,255,073 NS	FIGI
abrdn Healthcare Investors —	—	$19.84M	1.74%	2,083,921 NS	FIGI
abrdn Healthcare Opportunities Fund —	—	$18.67M	2.59%	1,960,732 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$16.33M	0.20%	1,715,826 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$15.67M	0.13%	1,645,746 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$15.41M	0.04%	1,618,364 NS	FIGI
College Retirement Equities Fund - Total Global… College Retirement Equities Fund	—	$13.34M	0.01%	1,401,210 NS	FIGI
abrdn Life Sciences Investors —	—	$9.48M	1.69%	996,017 NS	FIGI
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS	—	$7.09M	0.29%	744,480 NS	FIGI
AMG GW&K Small Cap Core Fund AMG Funds	—	$6.65M	0.99%	698,156 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERBCRX
FIGI_COMPOSITEBBG000BLYWX6
FIGI_SHARE_CLASSBBG001S7K151
CIK0000882796
ISINUS09058V1035
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: BioCryst is a biopharmaceutical company developing novel oral therapies for rare diseases, fitting the biotechnology industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.